| Unbound MEDLINE results for: | Bookmark this site | | Articles related to 18829912 [Unique ID], provided by the PubMed system | |
| |
|
| | 1 - 10 of 116 journal articles in the PubMed database | Email to a friend | | |
| Rabenda V, Vanoverloop J, Fabri V, et al.
Low incidence of anti-osteoporosis treatment after hip fracture. [Journal Article]
J Bone Joint Surg Am 2008 Oct; 90(10):2142-8.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Penning-van Beest FJ, Goettsch WG, Erkens JA, et al.
Determinants of persistence with bisphosphonates: a study in women with postmenopausal osteoporosis. [Journal Article]
Clin Ther 2006 Feb; 28(2):236-42.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cramer JA, Amonkar MM, Hebborn A, et al.
Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis. [Journal Article]
Curr Med Res Opin 2005 Sep; 21(9):1453-60.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Siris ES, Harris ST, Rosen CJ, et al.
Adherence to bisphosphonate therapy and fracture rates in osteoporotic women: relationship to vertebral and nonvertebral fractures from 2 US claims databases. [Journal Article]
Mayo Clin Proc 2006 Aug; 81(8):1013-22.
Abstract | Full Citation | Find Related Articles | | Brecht JG, Kruse HP, Möhrke W, et al.
Health-economic comparison of three recommended drugs for the treatment of osteoporosis. [Journal Article]
Int J Clin Pharmacol Res 2004; 24(1):1-10.
Abstract | Full Citation | Find Related Articles | | Mamdani M, Kopp A, Hawker G
Hip fractures in users of first- vs. second-generation bisphosphonates. [JOURNAL ARTICLE]
Osteoporos Int 2007 Sep 1.
Abstract | Full Citation | Find Related Articles | | Turbí C, Herrero-Beaumont G, Acebes JC, et al.
Compliance and satisfaction with raloxifene versus alendronate for the treatment of postmenopausal osteoporosis in clinical practice: An open-label, prospective, nonrandomized, observational study. [Clinical Trial, Journal Article, Multicenter Study]
Clin Ther 2004 Feb; 26(2):245-56.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Rabenda V, Mertens R, Fabri V, et al.
Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women. [JOURNAL ARTICLE]
Osteoporos Int 2007 Nov 13.
Abstract | Full Citation | Find Related Articles | | Stevenson M, Lloyd Jones M, De Nigris E, et al.
A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. [Journal Article]
Health Technol Assess 2005 Jun; 9(22):1-160.
Abstract | Full Citation | Publisher Full Text | Find Related Articles |   |
|
| |
Advertise on this site.
|
